FINWIRES · TerminalLIVE
FINWIRES

Alphabet 第一季度业绩超出预期,谷歌云和服务业务表现强劲

By

-- Alphabet(GOOG,GOOGL)第一季度业绩超出华尔街预期,谷歌云和服务业务营收大幅增长。 每股收益从去年同期的2.81美元增至5.11美元,高于FactSet根据GAAP准则预测的2.63美元。营收增长22%至1099亿美元,高于华尔街预期的1069.6亿美元。 该公司股价在盘后交易中上涨5.4%。 Alphabet表示,受企业人工智能解决方案和基础设施的推动,谷歌云业务销售额飙升63%至200.3亿美元。 谷歌服务业务第一季度营收增长16%至896.4亿美元,主要得益于广告收入从668.9亿美元跃升至772.5亿美元。 “在Gemini App的推动下,我们消费者人工智能计划在本季度取得了有史以来最强劲的业绩,”Alphabet和谷歌首席执行官桑达尔·皮查伊在一份声明中表示。“付费订阅用户总数已达到3.5亿,其中YouTube和Google One是主要驱动力。” Wedbush Securities此前预计Alphabet的业绩将“再次超出预期”,并表示华尔街低估了云计算、人工智能搜索和YouTube的增长潜力。 Wedbush分析师丹·艾夫斯等在周三财报发布前的一份报告中指出:“这份财报将进一步巩固Alphabet在垂直整合的人工智能飞轮上的良好发展前景,该飞轮涵盖Gemini 3、定制(张量处理单元)芯片、年化收入超过700亿美元的超大规模云业务以及其极具价值的消费者广告资产。” 截至周三收盘,Alphabet股价今年迄今已上涨约11%。

Related Articles

Asia

Electro Optic Systems Reports Contract Backlog Growth as of March 31

Electro Optic Systems Holdings (ASX:EOS) reported a contract backlog of AU$518 million as of March 31, up 13% from the end of 2025, according to a Thursday filing with the Australian bourse.The company closed the March quarter with unrestricted cash holdings of AU$95.1 million, representing a decrease of AU$11.8 million from the end of 2025, per the filing.

$ASX:EOS
Asia

Regis Healthcare Expects Fiscal 2026 Underlying EBITDA at Top End of Guidance

Regis Healthcare (ASX:REG) said it expects fiscal 2026 underlying earnings before interest, taxes, depreciation, and amortization (EBITDA) of about AU$135 million, at the top end of guidance, according to a Thursday Australian bourse filing.Occupancy across mature homes averaged about 96% in the fiscal third quarter, per the filing.The company said it generated net refundable accommodation deposit (RAD) cash inflows of AU$44.5 million in the third quarter, taking the total net RAD cash inflows for the year to date to AU$223 million.As resident turnover occurs, the progressive repricing of existing paid-up RADs to current advertised room prices is expected to generate net operating cash inflows of about AU$400 million over time while also increasing RAD retention earnings, the company added.

$ASX:REG
Research

Research Alert: CFRA Keeps Hold Opinion On Shares Of Mondelez International

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Our 12-month target price of $63, raised $1, reflects a 19x multiple of projected 2027 EPS, in line with MDLZ's historical forward P/E average. We raise our 2026 EPS estimate by $0.06 to $3.08, but cut 2027's by $0.11 to $3.32. We continue to see headwinds related to chocolate and biscuits divisions, though favorable forex has been helping to a degree. MDLZ highlighted plans to stimulate growth with more promotional activity, which could boost revenues (we see an acceleration in revenues in 2027), but may come with the trade-off of narrower margins. We note that cost-saving efforts can also contribute to staving off some of the margin pressure. MDLZ is largely hedged on its cocoa input costs for 2026 but less so in 2027. Thus, if the substantial rise in cocoa pricing in 2025 does not reemerge, it should help the bottom line in 2027 as cost pressures should ease. Share buybacks have also contributed to EPS, and we note that Q1 2026 share count was down 1.5% from one year earlier.

$MDLZ